News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
272,552 Results
Type
Article (14457)
Company Profile (281)
Press Release (257813)
Multimedia
Podcasts (59)
Webinars (9)
Section
Business (79635)
Career Advice (153)
Deals (13262)
Drug Delivery (35)
Drug Development (50533)
Employer Resources (31)
FDA (5763)
Job Trends (5148)
News (144640)
Policy (10047)
Tag
Academia (916)
Accelerated approval (5)
Adcomms (14)
Allergies (60)
Alliances (21760)
ALS (83)
Alzheimer's disease (919)
Antibody-drug conjugate (ADC) (130)
Approvals (5797)
Artificial intelligence (156)
Autoimmune disease (26)
Automation (6)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (59)
Biotechnology (231)
Bladder cancer (70)
Brain cancer (27)
Breast cancer (214)
Cancer (1949)
Cardiovascular disease (145)
Career advice (135)
Career pathing (2)
CAR-T (150)
CDC (4)
Cell therapy (400)
Cervical cancer (10)
Clinical research (41843)
Collaboration (715)
Company closure (1)
Compensation (353)
Complete response letters (19)
COVID-19 (1055)
CRISPR (63)
C-suite (237)
Cystic fibrosis (88)
Data (2199)
Denatured (13)
Depression (50)
Diabetes (178)
Diagnostics (1317)
Digital health (3)
Diversity (3)
Diversity, equity & inclusion (9)
Drug discovery (107)
Drug pricing (33)
Drug shortages (3)
Duchenne muscular dystrophy (142)
Earnings (30469)
Editorial (20)
Employer branding (4)
Employer resources (29)
Events (49583)
Executive appointments (551)
FDA (6762)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (628)
Gene editing (126)
Generative AI (11)
Gene therapy (335)
GLP-1 (416)
Government (1104)
Grass and pollen (2)
Guidances (93)
Healthcare (6602)
HIV (12)
Huntington's disease (29)
IgA nephropathy (38)
Immunology and inflammation (118)
Immuno-oncology (6)
Indications (25)
Infectious disease (1130)
Inflammatory bowel disease (125)
Inflation Reduction Act (9)
Influenza (25)
Intellectual property (87)
Interviews (18)
IPO (7314)
IRA (11)
Job creations (865)
Job search strategy (127)
Kidney cancer (8)
Labor market (11)
Layoffs (224)
Leadership (4)
Legal (1393)
Liver cancer (34)
Longevity (8)
Lung cancer (271)
Lymphoma (142)
Machine learning (6)
Management (7)
Manufacturing (202)
MASH (80)
Medical device (2613)
Medtech (2614)
Mergers & acquisitions (6383)
Metabolic disorders (488)
Multiple sclerosis (67)
NASH (13)
Neurodegenerative disease (104)
Neuropsychiatric disorders (32)
Neuroscience (1464)
NextGen: Class of 2025 (2021)
Non-profit (856)
Now hiring (24)
Obesity (228)
Opinion (105)
Ovarian cancer (86)
Pain (58)
Pancreatic cancer (88)
Parkinson's disease (153)
Partnered (8)
Patents (187)
Patient recruitment (122)
Peanut (38)
People (25953)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14786)
Phase II (19465)
Phase III (12289)
Pipeline (1140)
Policy (67)
Postmarket research (853)
Preclinical (6280)
Press Release (30)
Prostate cancer (87)
Psychedelics (41)
Radiopharmaceuticals (220)
Rare diseases (371)
Real estate (1425)
Recruiting (12)
Regulatory (8932)
Reports (18)
Research institute (943)
Resumes & cover letters (17)
Rett syndrome (8)
RNA editing (12)
RSV (11)
Schizophrenia (79)
Series A (119)
Series B (81)
Service/supplier (1)
Sickle cell disease (50)
Special edition (13)
Spinal muscular atrophy (118)
Sponsored (13)
Startups (1985)
State (1)
Stomach cancer (5)
Supply chain (26)
Tariffs (15)
The Weekly (45)
Vaccines (252)
Venture capital (41)
Weight loss (116)
Women's health (17)
Worklife (2)
Date
Today (5)
Last 7 days (298)
Last 30 days (992)
Last 365 days (18437)
2025 (10730)
2024 (20550)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10393)
2013 (7485)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (150)
Alabama (52)
Alaska (2)
Arizona (56)
Arkansas (5)
Asia (17630)
Australia (2990)
California (4868)
Canada (1381)
China (487)
Colorado (181)
Connecticut (179)
Delaware (141)
Europe (37884)
Florida (615)
Georgia (151)
Hawaii (2)
Idaho (16)
Illinois (291)
India (13)
Indiana (116)
Iowa (7)
Japan (126)
Kansas (67)
Kentucky (6)
Louisiana (4)
Maine (11)
Maryland (562)
Massachusetts (3903)
Michigan (86)
Minnesota (183)
Mississippi (3)
Missouri (25)
Montana (14)
Nebraska (4)
Nevada (21)
New Hampshire (14)
New Jersey (1203)
New Mexico (12)
New York (1286)
North Carolina (635)
North Dakota (6)
Northern California (2189)
Ohio (132)
Oklahoma (9)
Oregon (21)
Pennsylvania (917)
Puerto Rico (7)
Rhode Island (21)
South America (209)
South Carolina (6)
Southern California (1865)
Tennessee (29)
Texas (600)
United States (16559)
Utah (68)
Virginia (106)
Washington D.C. (36)
Washington State (418)
West Virginia (1)
Wisconsin (26)
272,552 Results for "cesca therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NeuroEM Therapeutics(R) Closes Initial Rounds in $5 Million Equity Raise to Commercialize Drug-free Alzheimer’s Treatment
June 16, 2025
·
4 min read
Press Releases
Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call
August 1, 2025
·
1 min read
Press Releases
Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics
July 3, 2025
·
7 min read
Press Releases
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
July 8, 2025
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Rein Therapeutics Enters into Agreements for up to $21 Million in Flexible Financing
July 31, 2025
·
5 min read
Press Releases
MapLight Therapeutics Announces $372.5 Million Series D Financing
July 29, 2025
·
5 min read
Press Releases
Aclaris Therapeutics Announces Leadership Transition
July 29, 2025
·
5 min read
Press Releases
Amicus Therapeutics Announces Second Quarter 2025 Financial Results and Corporate Updates
July 31, 2025
·
18 min read
Press Releases
ME Therapeutics Receives Support to Advance mRNA Therapeutic Candidates for Cancer and Inflammatory Disease
May 21, 2025
·
4 min read
1 of 27,256
Next
